PRIALT Side Effects

7003587-8 | Cerebellar Syndrome, Dyspnoea
on Sep 01, 2010 Male patient from FRANCE , weighting 209.4 lb, was diagnosed with neuralgia and was treated with Prialt (View Usage). Patient experienced the following unwanted or unexpected effects: cerebellar syndrome, dyspnoea. Prialt dosage: 0.05-0.15 Ug/hour Intrathecal. During the same period patient was treated with MORPHINE CHLORHYDRATE (View Morphine Chlorhydrate Review and Morphine Chlorhydrate Label ). Patient was hospitalized.

6946778-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Restless Legs Syndrome, Sensory Disturbance
Patient was taking Prialt (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, restless legs syndrome, sensory disturbance on Aug 10, 2010 from GERMANY Additional patient health information: Male patient , 48 years of age, was diagnosed with pain (What is pain?) and. Prialt dosage: 0.042 Ug/hr -0.083 Ug/hr. During the same period patient was treated with MST (View Mst Review and Mst Label ), ARCOXIA (View Arcoxia Review and Arcoxia Label ), SPASMEX (View Spasmex Review and Spasmex Label ). Patient was hospitalized.

6914459-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Restless Legs Syndrome, Sensory Disturbance
Adverse event was reported on Jul 19, 2010 by a Male patient taking Prialt (View Usage) (Dosage: 0.042 Ug/hr -0.083 Ug/hr) was diagnosed with pain (What is pain?) and. Location: GERMANY , 48 years of age, After Prialt was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, restless legs syndrome, sensory disturbance. During the same period patient was treated with MST (View Mst Review and Mst Label ), ARCOXIA (View Arcoxia Review and Arcoxia Label ), SPASMEX (View Spasmex Review and Spasmex Label ). Patient was hospitalized.

6876964-3 | Aphasia, Burning Sensation, Fall, Inappropriate Affect, Movement Disorder, Screaming
on Jul 27, 2010 Female patient from UNITED STATES , 49 years of age, weighting 223.0 lb, was diagnosed with neuropathy peripheral and was treated with Prialt (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), burning sensation, fall (What is fall?), inappropriate affect, movement disorder (What is movement disorder?), screaming. Prialt dosage: 3.501ug/day Daily It. Patient was hospitalized.


6836788-X | Agitation, Back Pain, Cardiac Stress Test Abnormal, Chest Pain, Confusional State, Dysmorphism, Electrocardiogram Abnormal, Granuloma, Hallucination, Auditory
on Jun 23, 2010 Female patient from UNITED STATES , 49 years of age, was diagnosed with back pain (What is back pain?), pain in extremity and was treated with Prialt (View Usage). Patient had the following side effects: agitation, back pain (What is back pain?), cardiac stress test abnormal, chest pain (What is chest pain?), confusional state, dysmorphism, electrocardiogram abnormal, granuloma, hallucination, auditory. Prialt dosage: 0.006-0.17 Ug/hr. During the same period patient was treated with LYRICA (View Lyrica Review and Lyrica Label ), PROVIGIL (View Provigil Review and Provigil Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), COPAXONE (View Copaxone Review and Copaxone Label ), WELLLBUTRIN (View Welllbutrin Review and Welllbutrin Label ), PROZAC (View Prozac Review and Prozac Label ). Patient was hospitalized.

6768850-4 | Aphasia, Thinking Abnormal
Patient was taking Prialt (View Usage). After Prialt was administered, patient had the following side effects: aphasia (What is aphasia?), thinking abnormal on May 26, 2010 from GERMANY Additional patient health information: Female patient , 42 years of age, was diagnosed with post laminectomy syndrome and. Prialt dosage: 1.2 Mg - 9 Mcg, Daily. During the same period patient was treated with ... (View ... Review and ... Label ), HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), LYRICA (View Lyrica Review and Lyrica Label ), KATADOLON (View Katadolon Review and Katadolon Label ), ARCOXIA (View Arcoxia Review and Arcoxia Label ), ORAMPRPH (View Oramprph Review and Oramprph Label ), ATOSIL (View Atosil Review and Atosil Label ). Patient was hospitalized.

6768848-6 | Balance Disorder, Dyskinesia, Feeling Cold, Hyperhidrosis, Memory Impairment, Speech Disorder
Adverse event was reported on May 26, 2010 by a Female patient taking Prialt (View Usage) (Dosage: 1.2 Mcg - 9 Mcg Daily;) was diagnosed with post laminectomy syndrome and. Location: GERMANY , 42 years of age, Patient experienced the following unwanted or unexpected effects: balance disorder, dyskinesia, feeling cold, hyperhidrosis, memory impairment, speech disorder. During the same period patient was treated with ... (View ... Review and ... Label ), HYDROMORPHONE (View Hydromorphone Review and Hydromorphone Label ), DULOXETINE (View Duloxetine Review and Duloxetine Label ), PREGABALIN (View Pregabalin Review and Pregabalin Label ), FLUPRITINE (View Flupritine Review and Flupritine Label ), ETORICOXIB (View Etoricoxib Review and Etoricoxib Label ), MORPHINE (View Morphine Review and Morphine Label ), ISOPROMETHAZINE (View Isopromethazine Review and Isopromethazine Label ). Patient was hospitalized.

6752480-4 | Paraplegia
on Jun 01, 2010 Female patient from UNITED STATES , weighting 180.0 lb, was diagnosed with back pain (What is back pain?) and was treated with Prialt (View Usage). Patient had the following side effects: paraplegia. Prialt dosage: ? Once It. During the same period patient was treated with INTRATHECAL PUMP (View Intrathecal Pump Review and Intrathecal Pump Label ). Patient was hospitalized.

6742048-8 | Depression, Dissociative Amnesia, Suicidal Ideation
on May 07, 2010 Female patient from GERMANY , 39 years of age, weighting 183.0 lb, was diagnosed with pain (What is pain?) and was treated with Prialt (View Usage). After Prialt was administered, patient had the following side effects: depression (What is depression?), dissociative amnesia, suicidal ideation. Prialt dosage: 0.25 Ug, Once/hour, Intrathecal. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), ARCOXIA (View Arcoxia Review and Arcoxia Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), LYRICA (View Lyrica Review and Lyrica Label ), KATADOLON /00830102/ (FLUPIRITINE MALEATE) (View Katadolon /00830102/ (flupiritine Maleate) Review and Katadolon /00830102/ (flupiritine Maleate) Label ), FLUCTINE (FLUOXETINE HYDROCHLORIDE) (View Fluctine (fluoxetine Hydrochloride) Review and Fluctine (fluoxetine Hydrochloride) Label ). Patient was hospitalized.

6738058-7 | Aphasia, Balance Disorder, Coma, Confusional State, Dizziness, Dyskinesia, Feeling Cold, Hyperhidrosis
Patient was taking Prialt (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), balance disorder, coma, confusional state, dizziness (What is dizziness?), dyskinesia, feeling cold, hyperhidrosis on May 05, 2010 from GERMANY Additional patient health information: Female patient , 42 years of age, was diagnosed with post laminectomy syndrome and. Prialt dosage: See Image. Patient was hospitalized.

6730944-7 | Depression, Dissociative Amnesia, Road Traffic Accident, Suicidal Ideation
Adverse event was reported on May 03, 2010 by a Female patient taking Prialt (View Usage) (Dosage: 0.25 Ug, Once/hour, Intrathecal) was diagnosed with pain (What is pain?) and. Location: GERMANY , 39 years of age, weighting 183.0 lb, Patient had the following side effects: depression (What is depression?), dissociative amnesia, road traffic accident, suicidal ideation. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PANTOZOL (PANTOPRAZOLE SODIUM0 (View Pantozol (pantoprazole Sodium0 Review and Pantozol (pantoprazole Sodium0 Label ), ARCOXIA (View Arcoxia Review and Arcoxia Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), LYRICA (View Lyrica Review and Lyrica Label ), FLUPIRTINE MALEATE (View Flupirtine Maleate Review and Flupirtine Maleate Label ). Patient was hospitalized.

6720605-2 | Burning Sensation, Disease Recurrence, Mental Status Changes, Muscle Spasms, Oral Discomfort, Oropharyngeal Blistering, Pancreatic Carcinoma, Pneumonia
on Apr 22, 2010 Male patient from UNITED STATES , 76 years of age, was diagnosed with neuropathy peripheral and was treated with Prialt (View Usage). After Prialt was administered, patient had the following side effects: burning sensation, disease recurrence, mental status changes, muscle spasms, oral discomfort, oropharyngeal blistering, pancreatic carcinoma, pneumonia (What is pneumonia?). Prialt dosage: Once/hour, Intrathecal; 0.07 Ug, Once/hour, Intrathecal; Intrathecal. During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ), BUPIVACAINE (BUPIVACAINE) (View Bupivacaine (bupivacaine) Review and Bupivacaine (bupivacaine) Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), NEXIUM (View Nexium Review and Nexium Label ). Patient was hospitalized.

6695442-8 | Amnesia, Psychotic Behaviour
on Apr 22, 2010 Male patient from UNITED STATES , weighting 178.0 lb, was treated with Prialt (View Usage). Patient experienced the following unwanted or unexpected effects: amnesia, psychotic behaviour. Prialt dosage: By Thecal Pump. Patient was hospitalized.

6679873-8 | Ataxia, Confusional State, Dysphagia, Hallucinations, Mixed, Pneumonia Aspiration, Psychotic Disorder, Withdrawal Syndrome
Patient was taking Prialt (View Usage). Patient had the following side effects: ataxia (What is ataxia?), confusional state, dysphagia, hallucinations, mixed, pneumonia aspiration, psychotic disorder (What is psychotic disorder?), withdrawal syndrome on Mar 26, 2010 from UNITED STATES Additional patient health information: Female patient , 65 years of age, was diagnosed with back pain (What is back pain?) and. Prialt dosage: 0.042 Ug, Once/hour, Intrathecal. During the same period patient was treated with HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ), BUPIVACAINE (BUPIVACAINE) (View Bupivacaine (bupivacaine) Review and Bupivacaine (bupivacaine) Label ). Patient was hospitalized.

6649033-5 | Coma, Confusional State, Hyperaesthesia, Overdose, Respiratory Failure
Adverse event was reported on Mar 09, 2010 by a Male patient taking Prialt (View Usage) (Dosage: Intrathecal ; 0.291 Ug, Once/hour, Intrathecal) was diagnosed with neuralgia and. Location: GERMANY , 52 years of age, After Prialt was administered, patient had the following side effects: coma, confusional state, hyperaesthesia, overdose, respiratory failure. During the same period patient was treated with PALLADONE (96 Mg, Once/day) (View Palladone Review and Palladone Label ), DULOXETINE HYDROCHLORIDE (View Duloxetine Hydrochloride Review and Duloxetine Hydrochloride Label ), LAXOBERAL (SODIUM PICOSULFATE) (View Laxoberal (sodium Picosulfate) Review and Laxoberal (sodium Picosulfate) Label ). Patient was hospitalized.

6610999-0 | Hallucination, Hyperthermia, Incoherent, Mental Disorder, Obsessive-compulsive Disorder, Weight Decreased
on Feb 08, 2010 Male patient from FRANCE , 42 years of age, weighting 160.9 lb, was treated with Prialt (View Usage). Patient experienced the following unwanted or unexpected effects: hallucination, hyperthermia, incoherent, mental disorder, obsessive-compulsive disorder (What is obsessive-compulsive disorder?), weight decreased. Prialt dosage: , Once/hour, Intrathecal , 0.375 Ug, Once/hour, Intrathecal. During the same period patient was treated with BACLOFEN (View Baclofen Review and Baclofen Label ). Patient was hospitalized.

6569449-5 | Graft Complication, Hypersensitivity, Medical Device Complication, Thermal Burn, Tinnitus
on Feb 02, 2010 Female patient from UNITED STATES , 52 years of age, weighting 150.0 lb, was diagnosed with pain (What is pain?) and was treated with Prialt (View Usage). Patient had the following side effects: graft complication, hypersensitivity, medical device complication, thermal burn, tinnitus (What is tinnitus?). Prialt dosage: .

6536846-3 | Cystitis, Pneumonia
Patient was taking Prialt (View Usage). After Prialt was administered, patient had the following side effects: cystitis, pneumonia (What is pneumonia?) on Dec 23, 2009 from UNITED STATES Additional patient health information: Male patient , 66 years of age, was diagnosed with pain (What is pain?) and. Prialt dosage: 0.038 Ug, Once/hour, Intrathecal. During the same period patient was treated with LIORESAL (View Lioresal Review and Lioresal Label ).

6525074-3 | Balance Disorder, Coma, Confusional State, Dizziness, Dyskinesia, Feeling Cold, Hyperhidrosis, Memory Impairment, Somnolence
Adverse event was reported on Dec 10, 2009 by a Female patient taking Prialt (View Usage) (Dosage: See Image) was diagnosed with post laminectomy syndrome and. Location: GERMANY , 42 years of age, Patient experienced the following unwanted or unexpected effects: balance disorder, coma, confusional state, dizziness (What is dizziness?), dyskinesia, feeling cold, hyperhidrosis, memory impairment, somnolence. Patient was hospitalized.

6522153-1 | Atelectasis, Blood Culture Positive, Confusional State, Hallucination, Auditory, Headache, Hypophagia, Mental Status Changes, Photophobia
on Dec 14, 2009 Male patient from UNITED STATES , 53 years of age, was diagnosed with back pain (What is back pain?), pain in extremity and was treated with Prialt (View Usage). Patient had the following side effects: atelectasis, blood culture positive, confusional state, hallucination, auditory, headache (What is headache?), hypophagia, mental status changes, photophobia. Prialt dosage: 0.013 Ug, Once/hour, Intrathecal. During the same period patient was treated with SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), DILAUDID (HYDROMOEPHON HYDROCHLORIDE) (View Dilaudid (hydromoephon Hydrochloride) Review and Dilaudid (hydromoephon Hydrochloride) Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), TYLENOL /00020001/(PARACETAMOL) (View Tylenol /00020001/(paracetamol) Review and Tylenol /00020001/(paracetamol) Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), SENOKOT /00142201/ (SENNA ALEXANDRINA) (View Senokot /00142201/ (senna Alexandrina) Review and Senokot /00142201/ (senna Alexandrina) Label ), ZOFRAN /00955301/ (ONDANSETRON) (View Zofran /00955301/ (ondansetron) Review and Zofran /00955301/ (ondansetron) Label ). Patient was hospitalized.

6509466-4 | Delirium, Depression, Oxygen Saturation Decreased, Psychotic Behaviour, Sedation
on Feb 27, 2009 Male patient from AUSTRIA , 75 years of age, weighting 154.3 lb, was diagnosed with neuralgia and was treated with Prialt (View Usage). After Prialt was administered, patient had the following side effects: delirium, depression (What is depression?), oxygen saturation decreased, psychotic behaviour, sedation. Prialt dosage: See Image. During the same period patient was treated with LIORESAL (View Lioresal Review and Lioresal Label ), TRADOLAN (TRAMADOL HYDROCHLORIDE) (View Tradolan (tramadol Hydrochloride) Review and Tradolan (tramadol Hydrochloride) Label ), TRAZODONE HYDROCHLORIDE (View Trazodone Hydrochloride Review and Trazodone Hydrochloride Label ), LYRICA (View Lyrica Review and Lyrica Label ), ESCITALOPRAM (View Escitalopram Review and Escitalopram Label ). Patient was hospitalized.

6509465-2 | Aggression, Agitation, Confusional State, Dysphoria, Escherichia Sepsis, Hallucination, Suicide Attempt, Urinary Tract Infection
Patient was taking Prialt (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, agitation, confusional state, dysphoria, escherichia sepsis, hallucination, suicide attempt, urinary tract infection (What is urinary tract infection?) on Sep 04, 2009 from FRANCE Additional patient health information: Male patient , 64 years of age, was diagnosed with neuralgia and. Prialt dosage: See Image. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), CATAPRES (View Catapres Review and Catapres Label ). Patient was hospitalized.

6489685-6 | Hepatic Enzyme Abnormal
Adverse event was reported on Nov 19, 2009 by a Male patient taking Prialt (View Usage) (Dosage: 0.083 Ug, Once/hour, Intrathecal; 0.041 Ug, Once/hour, Intrathecal) was diagnosed with pain (What is pain?) and. Location: GERMANY , 63 years of age, Patient had the following side effects: hepatic enzyme abnormal.

6468218-4 | Aggression, Anger, Blood Creatinine Increased, Blood Glucose Decreased, Blood Urea Increased, Dementia, Hallucination, Hypotension, Mental Status Changes
on Nov 10, 2009 Female patient from UNITED STATES , 62 years of age, was diagnosed with muscle spasms, pain (What is pain?) and was treated with Prialt (View Usage). After Prialt was administered, patient had the following side effects: aggression, anger, blood creatinine increased, blood glucose decreased, blood urea increased, dementia (What is dementia?), hallucination, hypotension, mental status changes. Prialt dosage: 2.083 Ug, Once/hour, Intrathecal. During the same period patient was treated with BACLOFEN (View Baclofen Review and Baclofen Label ), MORPHINE (View Morphine Review and Morphine Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), MAGNESIUM OXIDE (MAGNESIUM OXIDE) (View Magnesium Oxide (magnesium Oxide) Review and Magnesium Oxide (magnesium Oxide) Label ), HEMOCYTE (FERROUS FUMARATE) (View Hemocyte (ferrous Fumarate) Review and Hemocyte (ferrous Fumarate) Label ), RENAGEL (View Renagel Review and Renagel Label ), AMARYL (View Amaryl Review and Amaryl Label ). Patient was hospitalized.

6416308-4 | Coma, Confusional State, Dizziness, Somnolence
on Oct 12, 2009 Female patient from GERMANY , 42 years of age, was diagnosed with post laminectomy syndrome and was treated with Prialt (View Usage). Patient experienced the following unwanted or unexpected effects: coma, confusional state, dizziness (What is dizziness?), somnolence. Prialt dosage: See Image; Intrathecal. During the same period patient was treated with HYDROMORPHONE HYDROCHLORIDE (View Hydromorphone Hydrochloride Review and Hydromorphone Hydrochloride Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), LYRICA (View Lyrica Review and Lyrica Label ). Patient was hospitalized.

6407818-4 | Confusional State, Erythema, Face Oedema, Pulmonary Embolism
Patient was taking Prialt (View Usage). Patient had the following side effects: confusional state, erythema, face oedema, pulmonary embolism (What is pulmonary embolism?) on Oct 07, 2009 from CZECH REPUBLIC Additional patient health information: Female patient , 41 years of age, weighting 176.4 lb, was diagnosed with post laminectomy syndrome and. Prialt dosage: 0.15 Ug, Once/hour, Intrathecal. During the same period patient was treated with TIAPRIDE (TIAPRIDE) (View Tiapride (tiapride) Review and Tiapride (tiapride) Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ). Patient was hospitalized.

6359461-3 | Coma, Dizziness
Adverse event was reported on Aug 31, 2009 by a Female patient taking Prialt (View Usage) (Dosage: See Image) was diagnosed with post laminectomy syndrome and. Location: GERMANY , 46 years of age, After Prialt was administered, patient had the following side effects: coma, dizziness (What is dizziness?). During the same period patient was treated with CYMBALTA (View Cymbalta Review and Cymbalta Label ), LYRICA (View Lyrica Review and Lyrica Label ), HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ).

6306930-8 | Activities Of Daily Living Impaired, Blood Pressure Increased, Confusional State, Dizziness, Dysgraphia, Headache, Lethargy, Nausea, Pain
on Aug 11, 2009 Female patient from UNITED STATES , 52 years of age, weighting 230.0 lb, was diagnosed with post laminectomy syndrome and was treated with Prialt (View Usage). Patient experienced the following unwanted or unexpected effects: activities of daily living impaired, blood pressure increased, confusional state, dizziness (What is dizziness?), dysgraphia, headache (What is headache?), lethargy, nausea (What is nausea?), pain (What is pain?). Prialt dosage: It.

6215615-8 | Delirium, Dizziness, Hallucinations, Mixed, Infection, Pyrexia
on Jun 03, 2009 Female patient from UNITED STATES , weighting 151.9 lb, was diagnosed with pain (What is pain?) and was treated with Prialt (View Usage). Patient had the following side effects: delirium, dizziness (What is dizziness?), hallucinations, mixed, infection (What is infection?), pyrexia. Prialt dosage: Pump. Patient was hospitalized.

6178737-6 | Hypersensitivity
Patient was taking Prialt (View Usage). After Prialt was administered, patient had the following side effects: hypersensitivity on Apr 15, 2009 from UNITED STATES Additional patient health information: Female patient , 50 years of age, weighting 220.0 lb, was diagnosed with post laminectomy syndrome and. Prialt dosage: 1 Ug, Single, Intrathecal; 0.033 Ug, Once/hour, Intrathecal. During the same period patient was treated with HYDROMORPHONE HCL (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), BUPIVACAINE (View Bupivacaine Review and Bupivacaine Label ).

6162971-5 | Cardiac Failure Congestive, Catheter Related Complication, Device Malfunction, Granuloma, Intervertebral Discitis, Neuralgia, Osteomyelitis, Pneumonia
Adverse event was reported on Dec 15, 2008 by a Female patient taking Prialt (View Usage) (Dosage: 1.325 Ug, Once/hour, Intrathecal) was diagnosed with pain in extremity, radiculopathy and. Location: UNITED STATES , 47 years of age, Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, catheter related complication, device malfunction, granuloma, intervertebral discitis, neuralgia, osteomyelitis, pneumonia (What is pneumonia?). During the same period patient was treated with SUFENTANIL CITRATE (View Sufentanil Citrate Review and Sufentanil Citrate Label ), BUPIVACAINE (View Bupivacaine Review and Bupivacaine Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), LAXATIVES (View Laxatives Review and Laxatives Label ), COUMADIN (View Coumadin Review and Coumadin Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), IMIPRAMINE (View Imipramine Review and Imipramine Label ). Patient was hospitalized.

6103486-X | Fall, Gait Disturbance, Myocardial Infarction, Myocardial Ischaemia, Respiratory Failure, Rhabdomyolysis, Speech Disorder, Vertigo
on Feb 13, 2009 Male patient from GERMANY , 67 years of age, was diagnosed with post laminectomy syndrome and was treated with Prialt (View Usage). Patient had the following side effects: fall (What is fall?), gait disturbance, myocardial infarction, myocardial ischaemia, respiratory failure, rhabdomyolysis, speech disorder, vertigo. Prialt dosage: See Image. During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6083819-3 | Catheter Related Complication, Faecal Incontinence, Granuloma, Infusion Site Mass, Muscular Weakness, Pain In Extremity, Urinary Incontinence
on Feb 03, 2009 Female patient from UNITED STATES , 58 years of age, was diagnosed with pain (What is pain?) and was treated with Prialt (View Usage). After Prialt was administered, patient had the following side effects: catheter related complication, faecal incontinence, granuloma, infusion site mass, muscular weakness, pain in extremity, urinary incontinence (What is urinary incontinence?). Prialt dosage: 0.062 Ug, Once/hour, Intrathecal. During the same period patient was treated with MORPHINE (Intrathecal) (View Morphine Review and Morphine Label ), DILAUDID (View Dilaudid Review and Dilaudid Label ). Patient was hospitalized.

6076500-8 | Aphasia, Disorientation, Pneumonia, Somnolence, Transient Ischaemic Attack, Unresponsive To Stimuli
Patient was taking Prialt (View Usage). Patient experienced the following unwanted or unexpected effects: aphasia (What is aphasia?), disorientation, pneumonia (What is pneumonia?), somnolence, transient ischaemic attack, unresponsive to stimuli on Jan 22, 2009 from SWITZERLAND Additional patient health information: Female patient , 58 years of age, was diagnosed with pain (What is pain?) and. Prialt dosage: See Image. Patient was hospitalized.

6071627-9 | Angina Pectoris, Anxiety, Breast Disorder, Feeling Abnormal, Nausea, Speech Disorder, Tachycardia
Adverse event was reported on Jan 21, 2009 by a Female patient taking Prialt (View Usage) (Dosage: See Image) was diagnosed with sciatica (What is sciatica?) and. Location: GERMANY , 39 years of age, weighting 138.9 lb, Patient had the following side effects: angina pectoris, anxiety (What is anxiety?), breast disorder, feeling abnormal, nausea (What is nausea?), speech disorder, tachycardia. During the same period patient was treated with LAXOBERAL (SODIUM PICOSULFATE) (View Laxoberal (sodium Picosulfate) Review and Laxoberal (sodium Picosulfate) Label ). Patient was hospitalized.

6039349-8 | Angina Pectoris, Anxiety, Nausea, Sense Of Oppression, Speech Disorder, Tachycardia
on Dec 15, 2008 Female patient from GERMANY , 39 years of age, weighting 138.9 lb, was diagnosed with back pain (What is back pain?) and was treated with Prialt (View Usage). After Prialt was administered, patient had the following side effects: angina pectoris, anxiety (What is anxiety?), nausea (What is nausea?), sense of oppression, speech disorder, tachycardia. Prialt dosage: See Image. During the same period patient was treated with LAXOBERAL (SODIUM PICOSULFATE) (View Laxoberal (sodium Picosulfate) Review and Laxoberal (sodium Picosulfate) Label ). Patient was hospitalized.

5988615-0 | Pneumonia, Pulmonary Embolism, Sinus Tachycardia
on Nov 13, 2008 Female patient from GERMANY , 48 years of age, weighting 165.3 lb, was diagnosed with pain (What is pain?) and was treated with Prialt (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?), pulmonary embolism (What is pulmonary embolism?), sinus tachycardia. Prialt dosage: See Image. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ). Patient was hospitalized.

5976508-4 | Condition Aggravated, Convulsion, Glasgow Coma Scale Abnormal, Malaise, Pain
Patient was taking Prialt (View Usage). Patient had the following side effects: condition aggravated, convulsion, glasgow coma scale abnormal, malaise, pain (What is pain?) on Nov 06, 2008 from IRELAND Additional patient health information: Female patient , 40 years of age, weighting 145.5 lb, was diagnosed with pain (What is pain?) and. Prialt dosage: 0.425 Ug Once/hour, Intrathecal; 0.479 Ug Once/hour Intrathecal; 0.424 Ug Once/hour Intrathecal; 0.3. During the same period patient was treated with CYCLIMORPHICYCLIZINE TARTRATE, MORPHINE TARTRATE) (Unk, Single, Intramuscular) (View Cyclimorphicyclizine Tartrate, Morphine Tartrate) Review and Cyclimorphicyclizine Tartrate, Morphine Tartrate) Label ), ETORICOXIB (ETORICOXIB) (View Etoricoxib (etoricoxib) Review and Etoricoxib (etoricoxib) Label ), AMITRIPTYLINE HYDROCHLORIDE (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ). Patient was hospitalized.

5964620-5 | Convulsion, Malaise, Pain
Adverse event was reported on Nov 06, 2008 by a Female patient taking Prialt (View Usage) (Dosage: See Image.) was diagnosed with pain (What is pain?) and. Location: IRELAND , 40 years of age, weighting 145.5 lb, After Prialt was administered, patient had the following side effects: convulsion, malaise, pain (What is pain?). During the same period patient was treated with CYCLIMORPH(CYCLIZINE TARTRATE, MORPHINE TARTRATE) (Single, Intramuscular) (View Cyclimorph(cyclizine Tartrate, Morphine Tartrate) Review and Cyclimorph(cyclizine Tartrate, Morphine Tartrate) Label ), ETORICOXIB (ETORICOXIB) (View Etoricoxib (etoricoxib) Review and Etoricoxib (etoricoxib) Label ), AMITRIPTYLINE HYDROCHLORIDE (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ). Patient was hospitalized.

5964535-2 | Completed Suicide, Confusional State, Pain, Pyrexia
on Nov 22, 2008 Male patient from UNITED STATES , 48 years of age, weighting 185.0 lb, was treated with Prialt (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide, confusional state, pain (What is pain?), pyrexia. Prialt dosage: See Attached Form Letter.

5947787-4 | Pneumonia, Pulmonary Embolism
on Oct 23, 2008 Female patient from GERMANY , 48 years of age, weighting 165.3 lb, was diagnosed with pain (What is pain?) and was treated with Prialt (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?), pulmonary embolism (What is pulmonary embolism?). Prialt dosage: See Image; Intrathecal. During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ). Patient was hospitalized.

5924497-0 | Dizziness, Headache, Hyponatraemia, Somnolence
Patient was taking Prialt (View Usage). After Prialt was administered, patient had the following side effects: dizziness (What is dizziness?), headache (What is headache?), hyponatraemia, somnolence on Oct 02, 2008 from SPAIN Additional patient health information: Female patient , 63 years of age, weighting 187.4 lb, was diagnosed with myelitis and. Prialt dosage: 0.162 Ug, Once/hour, Inthrathecal. During the same period patient was treated with TEGRETOL (View Tegretol Review and Tegretol Label ). Patient was hospitalized.

5923817-0 | Hyponatraemia
Adverse event was reported on Oct 02, 2008 by a Female patient taking Prialt (View Usage) (Dosage: 0.162 Ug, Once/hour, Intrathecal) was diagnosed with myelitis and. Location: SPAIN , 63 years of age, weighting 187.4 lb, Patient experienced the following unwanted or unexpected effects: hyponatraemia. During the same period patient was treated with TEGRETOL (View Tegretol Review and Tegretol Label ). Patient was hospitalized.

5914509-2 | Convulsion, Malaise, Pain
on Sep 12, 2008 Female patient from IRELAND , 40 years of age, weighting 145.5 lb, was diagnosed with pain (What is pain?) and was treated with Prialt (View Usage). Patient had the following side effects: convulsion, malaise, pain (What is pain?). Prialt dosage: 0.425 Ug, Once/hour, Intrathecal. During the same period patient was treated with CYCLIMORPH(CYCLIZINE TARTRATE, MORPHINE TARTRATE) (Single, Intramuscular) (View Cyclimorph(cyclizine Tartrate, Morphine Tartrate) Review and Cyclimorph(cyclizine Tartrate, Morphine Tartrate) Label ), ETORICOXIB (ETORICOXIB) (View Etoricoxib (etoricoxib) Review and Etoricoxib (etoricoxib) Label ), AMITRIPTYLINE HYDROCHLORIDE (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), LANSOPRAZOLE (LANSOPRAZOLE) (View Lansoprazole (lansoprazole) Review and Lansoprazole (lansoprazole) Label ), FUSIDIC ACID (View Fusidic Acid Review and Fusidic Acid Label ), MINOCYCLINE HCL (View Minocycline Hcl Review and Minocycline Hcl Label ). Patient was hospitalized.

5914483-9 | Convulsion, Malaise, Pain
on Sep 23, 2008 Female patient from IRELAND , 40 years of age, weighting 145.5 lb, was diagnosed with pain (What is pain?) and was treated with Prialt (View Usage). After Prialt was administered, patient had the following side effects: convulsion, malaise, pain (What is pain?). Prialt dosage: 0.425 Ug, Once/hour, Intrathecal; Once/hour, Intrathecal. During the same period patient was treated with CYCLIMORPH(CYCLIZINE TARTRATE, MORPHINE TARTRATE) (Single, Intramuscular) (View Cyclimorph(cyclizine Tartrate, Morphine Tartrate) Review and Cyclimorph(cyclizine Tartrate, Morphine Tartrate) Label ), ETORICOXIB (ETORICOXIB) (View Etoricoxib (etoricoxib) Review and Etoricoxib (etoricoxib) Label ), AMITRIPTYLINE HYDROCHLORIDE (View Amitriptyline Hydrochloride Review and Amitriptyline Hydrochloride Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), FUSIDIC ACID (View Fusidic Acid Review and Fusidic Acid Label ). Patient was hospitalized.

5894572-8 | Respiratory Depression
Patient was taking Prialt (View Usage). Patient experienced the following unwanted or unexpected effects: respiratory depression on Sep 05, 2008 from UNITED STATES Additional patient health information: Female patient , 49 years of age, was diagnosed with radicular pain and. Prialt dosage: 0.14 Ug, Once/hour, Intrathecal, 0.05 Ug, Once/hour, Intrathecal. During the same period patient was treated with MS CONTIN (18.5 Mg, Once/day, Intrathecal) (View Ms Contin Review and Ms Contin Label ).

5875681-6 | Personality Change, Renal Disorder
Adverse event was reported on Aug 21, 2008 by a Female patient taking Prialt (View Usage) (Dosage: 0.02 Ug, Once/hour, Intrathecal; 0.062 Ug, Once/hour, Intrathecal; 0.041 Ug, Once/hour, Intrathecal) was diagnosed with back pain (What is back pain?), post laminectomy syndrome and. Location: UNITED STATES , 72 years of age, Patient had the following side effects: personality change, renal disorder.

5847520-0 | Confusional State, Conversion Disorder, Suicidal Ideation
on Jul 31, 2008 Female patient from UNITED STATES , 64 years of age, was diagnosed with pain (What is pain?) and was treated with Prialt (View Usage). After Prialt was administered, patient had the following side effects: confusional state, conversion disorder, suicidal ideation. Prialt dosage: 0.05 Ug, Once/hour, Intrathecal; 0.06 Ug, Once/hour, Intrathecal; 0.08 Ug, Once/hour, Intrathecal; 0. Patient was hospitalized.

5836902-9 | Cardiac Arrest, Unresponsive To Stimuli
on Jul 25, 2008 Female patient from UNITED STATES , 64 years of age, was diagnosed with pain (What is pain?) and was treated with Prialt (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), unresponsive to stimuli. Prialt dosage: 0.341 Ug, Once/hour, Intrathecal 0.376 Ug, Once/hour, Intrathecal. During the same period patient was treated with HYDROMORPHONE HCL (0.376 Mg, Once/hour, Intrathecal) (View Hydromorphone Hcl Review and Hydromorphone Hcl Label ), MS CONTIN (View Ms Contin Review and Ms Contin Label ), NITROQUICK (GLYCERYL TRINITRATE) (View Nitroquick (glyceryl Trinitrate) Review and Nitroquick (glyceryl Trinitrate) Label ), CARDIZEM (View Cardizem Review and Cardizem Label ), HEPARIN (View Heparin Review and Heparin Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), PLAVIX (View Plavix Review and Plavix Label ).

5813713-1 | Cardiac Disorder, Lung Disorder
Patient was taking Prialt (View Usage). Patient had the following side effects: cardiac disorder, lung disorder on Jun 27, 2008 from UNITED STATES Additional patient health information: Female patient , 64 years of age, . Prialt dosage: 0.341 Ug, Once/hour, Intrathecal; 0.375 Ug, Once/hour, Intrathecal. During the same period patient was treated with DILAUDID (View Dilaudid Review and Dilaudid Label ).